| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DNA | Class A Common Stock | Options Exercise | +6.13K | 6.13K | Sep 30, 2022 | Direct | F1, F2 | |||
| transaction | DNA | Class A Common Stock | Options Exercise | +226K | +3690.51% | 233K | Oct 1, 2022 | Direct | F3 | ||
| transaction | DNA | Class A Common Stock | Sale | -$8.5K | -2.72K | -1.17% | $3.12 | 230K | Oct 3, 2022 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DNA | Class B Common Stock | Options Exercise | -6.13K | -10.42% | 52.8K | Sep 30, 2022 | Class A Common Stock | Direct | F1, F2, F5 | ||||
| transaction | DNA | Restricted Stock Units | Award | +491K | +258.32% | 681K | Nov 17, 2021 | Class A Common Stock | Direct | F3, F6 | ||||
| transaction | DNA | Restricted Stock Units | Options Exercise | -226K | -33.86% | 442K | Oct 1, 2022 | Class A Common Stock | Direct | F3, F6 |
| Id | Content |
|---|---|
| F1 | Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. |
| F2 | Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| F3 | Represents restricted stock units (the "RSUs") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the "Merger"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. |
| F4 | Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a "sell to cover" transaction. |
| F5 | Includes shares of Class B Common Stock that are subject to vesting conditions. Excludes RSUs, which were previously reported as shares of Class B Common Stock on the Form 4 filed by the reporting person on March 14, 2022. Because the Issuer has the ability to settle such RSUs with shares of Class A Common Stock or cash upon vesting, RSUs will be reported separately from shares of Class B Common Stock in future reports. |
| F6 | Includes RSUs that are subject to vesting conditions. Includes 190,000 RSUs that were acquired after November 17, 2021. |
This Form 4 amends and restates the Form 4 filed by the Reporting Person on October 4, 2022. Chief Accounting Officer